Cipla Q1 profit miss

Indian drugmaker Cipla's Q1 profit misses estimates

Cipla's Q1 profit fell 39.2% to 7.89 billion rupees, missing estimates due to muted generic cancer drug sales and supply disruptions affecting lanreotide in its U.S. business.